scientifyRESEARCH
research funding database

RESEARCH FUNDING

2024 Preclinical / Translational Studies (osteosarcoma | worldwide)

Share

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Preclinical / Translational Studies Grant from the Osteosarcoma Institute supports translational researchers working on osteosarcoma. The proposed study should have a research agenda that will identify biological dependencies in the disease that can be targeted in patients. This research agenda will ideally include the use of novel laboratory approaches and bioinformatic tools applied to osteosarcoma cells, a diversity of in vivo models across species and human patient samples. Furthermore, we believe these dependencies will likely impact a variety of potential phenotypes associated with the disease, including metastatic proclivity, DDR in the context of a structurally complex genome, and resistance to first generation T cell checkpoint blockade. Applications are open to researchers based at non-profit organizations worldwide. Applicants must have an MD, PhD, MD/PhD, or equivalent and be appointed as faculty (or equivalent) at an academic institution. Applicants may apply for up to 500,000 USD, including up to 10% indirect costs for 2 years.

Letters of intent are due on November 15, 2023. Invited full applications are due on April 12, 2024.

Full application due:
April 12, 2024

non member

More related info for you

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.